| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/26/2011 | US7932252 CCR9 chemokine receptor modulators; treating inflammatory and immune diseases; inhibit the binding of chemokines, such as TECK (thymus-expressed chemokine), to the CCR9 receptor; 1-arylsulfonamido-2-aryl(alkyl)benzene compounds |
| 04/26/2011 | US7932246 Histone deacetylase inhibitors |
| 04/26/2011 | CA2634676C Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp |
| 04/26/2011 | CA2601458C Benzimidazolone derivatives as cb2 receptor ligands |
| 04/26/2011 | CA2583742C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 04/26/2011 | CA2508474C Pesticidal sulphonylaminopyrazoles |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/21/2011 | WO2011046970A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011045415A2 New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
| 04/21/2011 | WO2011045292A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes |
| 04/21/2011 | WO2011045271A1 Herbicidally active, heterocyclyl-substituted pyridazinones |
| 04/21/2011 | WO2011045084A1 Quinolinyloxyphenylsulfonamides |
| 04/21/2011 | WO2011026911A8 Bipyridines useful for the treatment of proliferative diseases |
| 04/21/2011 | WO2010141584A3 Antagonism of human formyl peptide receptor for treatment of disease |
| 04/21/2011 | WO2008080988A3 Cyclopentanone derivatives, method of synthesis and uses thereof |
| 04/21/2011 | US20110092707 Crystalline Pharmaceutical and Methods of Preparation and Use Thereof |
| 04/21/2011 | US20110092539 Indane derivatives as ampa receptor modulators |
| 04/21/2011 | US20110092533 Compounds for binding to er alpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof |
| 04/21/2011 | US20110092528 Piperidinyl compounds that selectively bind integrins |
| 04/21/2011 | US20110092496 Thiophene compounds and thrombopoietin receptor activators |
| 04/21/2011 | US20110092480 Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092460 Cyclopropyl polymerase inhibitors |
| 04/21/2011 | US20110092415 Anti-Viral Compounds |
| 04/21/2011 | US20110091459 Imidazole modulators of muscarinic acetylcholine receptor m3 |
| 04/21/2011 | US20110091382 Novel imaging agents for detecting neurological dysfunction |
| 04/21/2011 | US20110090338 Vehicular rearview mirror system |
| 04/21/2011 | CA2777762A1 Amino - pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilon |
| 04/21/2011 | CA2776457A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes |
| 04/20/2011 | EP2311831A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/20/2011 | EP2311829A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311827A1 Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators. |
| 04/20/2011 | EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/20/2011 | EP2311809A1 Quinolinyloxyphenylsulfonamides |
| 04/20/2011 | EP2311808A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311806A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 04/20/2011 | EP2311803A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | EP2311802A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | EP2310382A1 Amidophenoxyindazoles useful as inhibitors of c-met |
| 04/20/2011 | EP2310381A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer |
| 04/20/2011 | EP2310373A1 Bicyclic heterocycles as mek kinase inhibitors |
| 04/20/2011 | EP2310372A2 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 04/20/2011 | EP2310370A1 4, 6-diphenylpyrid-2-ones against cancer |
| 04/20/2011 | EP2310368A1 Small molecule leptin receptor modulators |
| 04/20/2011 | EP2310356A1 Adamantyl diamide derivatives and uses of same |
| 04/20/2011 | EP1781662B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
| 04/20/2011 | EP1292592B1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 04/20/2011 | CN1902194B Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methyl)-pyrrol-1-yl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
| 04/20/2011 | CN102026992A Novel HSP inhibitory carbazole derivatives, compositions containing same, and use thereof |
| 04/20/2011 | CN102026978A Pyridine compounds |
| 04/20/2011 | CN102026969A Novel N-(2-amino-phenyl)-acrylamides |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102024907A Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods |
| 04/20/2011 | CN102020727A Pyrazole oxime ester photoinitiator with high photosensibility, preparation method and application thereof |
| 04/20/2011 | CN102020640A Tetrahydroindolone and tetrahydroindolone derivative as well as preparation method and medical application thereof |
| 04/20/2011 | CN102020613A Amino sulfonylureas compound with herbicidal activity and the application thereof |
| 04/20/2011 | CN102020607A 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 04/20/2011 | CN101346349B Process for the production of ezetimibe and intermediates used in this proces |
| 04/20/2011 | CN101039935B New piperidine antibiotics |
| 04/20/2011 | CN101010312B Quaternary salt CCR2 antagonists |
| 04/19/2011 | US7928227 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 04/19/2011 | US7928224 Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | US7928133 Compounds and compositions as hedgehog signaling pathway modulators |
| 04/19/2011 | US7928128 Use of(R)-(−) -2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928122 Modulators of cellular adhesion |
| 04/19/2011 | CA2628963C Benzene derivative or salt thereof |
| 04/19/2011 | CA2621181C 5-isoquinolinesulfonamide compounds |
| 04/19/2011 | CA2539853C Isoquinolinone potassium channel inhibitors |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2464000C 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 04/14/2011 | WO2011044506A2 Sulphone compounds and methods of making and using same |
| 04/14/2011 | WO2011044197A1 Spirocyclic compounds as modulators of chemokine receptor activity |
| 04/14/2011 | WO2011044001A1 Compounds and compositions as modulators of gpr119 activity |
| 04/14/2011 | WO2011043479A1 Therapeutic agent for cerebral infarction |
| 04/14/2011 | WO2011042477A1 Substituted pyrroles and imidazoles as estrogen receptor ligands |
| 04/14/2011 | WO2011042475A1 Substituted pyrazoles as estrogen receptor ligands |
| 04/14/2011 | WO2010142766A3 Pyrimidine derivatives as zap-70 inhibitors |
| 04/14/2011 | US20110086885 Indole-2-carboxylic acid amides |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086863 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 04/14/2011 | US20110086860 Compound |
| 04/14/2011 | US20110086853 Therapeutic Compounds |
| 04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
| 04/14/2011 | US20110086817 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria |
| 04/14/2011 | CA2777108A1 Sulphone compounds and methods of making and using same |
| 04/14/2011 | CA2774573A1 Compounds and compositions as modulators of gpr119 activity |
| 04/13/2011 | EP2309505A1 Coloring matter for optical information recording medium and optical information recording medium |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308854A1 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 04/13/2011 | EP2308852A1 5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors |
| 04/13/2011 | EP2308848A1 Quinoline-derived amide modulators of vanilloid VR1 receptor |
| 04/13/2011 | EP2308562A2 Azetidine ring compounds and drugs comprising the same |
| 04/13/2011 | EP2307421A1 Oxindole compounds |
| 04/13/2011 | EP2307402A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors |